Status:
RECRUITING
Earlier Diagnosis and Better Treatment Mission Related to the Cohort Programme
Lead Sponsor:
Luxembourg Institute of Health
Collaborating Sponsors:
University of Luxembourg
Laboratoire National de Santé (LNS)
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Brief Summary
The Luxembourg Parkinson's Study is an ongoing longitudinal nationwide monocentric observational study. It collects extensive clinical, molecular, genetic, and digital device-based longitudinal data, ...
Eligibility Criteria
Inclusion
- Subjects with neurodegenerative disease or having Parkinson's disease (typical PD or atypical parkinsonism)
- Subjects of all genders with a full capacity of consent
- Subjects with a limited consent capacity if the legal guardian/authorised representative is in agreement
- Subjects of at least 18 years of age at the time of inclusion
Exclusion
- Refusal to sign the informed consent
- Limited capacity of consent on the part of the donor, if there is no legally determined guardian/authorised representative, or the latter is not present or does not agree with the inclusion
- Active cancer
- Pregnant women
- Underage subjects of less than 18 years of age
- Refusal to comply with mandatory sample collection
- For invasive procedures, i.e., lumbar puncture and skin biopsy: relevant blood clotting impairment, e.g., anamnestic evidence of frequent or prolonged bleedings.
Key Trial Info
Start Date :
December 19 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1800 Patients enrolled
Trial Details
Trial ID
NCT05266872
Start Date
December 19 2014
End Date
December 31 2025
Last Update
August 6 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Luxembourg (CHL), "Parkinson's Research Clinic"
Luxembourg, Luxembourg, 1210
2
Clinical and Epidemiological Investigation Center (CIEC)
Luxembourg, Luxembourg, 1445